Brave Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-261	Closed	-$274K	–	178
2024 Q3	$274K	Hold	261	–	–	0.07%	113
2024 Q2	$274K	Hold	261	–	–	0.07%	104
2024 Q1	$251K	Hold	261	–	–	0.07%	111
2023 Q4	$229K	Sell	261 -50	-16%	-$41.2K	0.06%	116
2023 Q3	$256K	Hold	311	–	–	0.08%	101
2023 Q2	$223K	Hold	311	–	–	0.07%	115
2023 Q1	$256K	Hold	311	–	–	0.08%	102
2022 Q4	$224K	Hold	311	–	–	0.08%	116
2022 Q3	$214K	Buy	+311	New	+$196K	0.11%	111
2022 Q2	–	Sell	-311	Closed	-$217K	–	162
2022 Q1	$217K	Buy	+311	New	+$197K	0.07%	131
2016 Q4	–	Sell	-420	Closed	-$169K	–	282
2016 Q3	$169K	Sell	420 -30	-7%	-$12K	0.11%	136
2016 Q2	$157K	Buy	+450	New	+$173K	0.11%	144